Dekker, P
Cette dernire semble apparatre chez des sujets en cours de traitement injectable, dans le cadre d'une anmie
Key index paths: Neuropathy, neuropathic main term subterm peripheral subterm by etiology (alcoholic, diabetic, drug-induced, hereditary, idiopathic, inflammatory, ischemic, toxic) Neuropathy, peripheral, diabetic see E08E13 with .40.49 Polyneuropathy main term subterms by etiology (alcoholic G62.1, critical illness G62.81, diabetic [see Diabetes, with neuropathy], drug-induced G62.0, hereditary G60.x, idiopathic G60.9, inflammatory G61.x, radiation G62.82, toxic G62.2) Syndrome, carpal tunnel G56.0- Syndrome, tarsal tunnel G57.5- Syndrome, Guillain-Barr G61.0 Neuropathy, CIDP G61.81 Disease, Charcot-Marie-Tooth G60.0 Meralgia paresthetica G57.1- Neuralgia, post-herpetic B02.29 (other PHN) or B02.22 (trigeminal) Degeneration, subacute combined G32.0 Dysautonomia G90.1 (familial), G90.09 (other idiopathic) Syndrome, Refsum G60.1 Coder Note When the index leads to see also Diabetes, with, neuropathy always confirm documentation of the specific type of diabetes (Type 1, Type 2, secondary, drug-induced) before selecting the E-code subcategory
CJC-1295 + Ipamorelin GH-axis stack referenced alongside AOD-9604 in growth-hormone-pathway research
The total annual cost for intramuscular injections for cohort 2 was $1.6 million (Table 3)
